Fostamatinib 150 mg

( DrugBank: Fostamatinib / KEGG DRUG: Fostamatinib )

1 disease

ID	Disease name (Link within this page)	Number of trials
66	IgA nephropathy	3

66. IgA nephropathy

Clinical trials : 275 / Drugs : 258 - (DrugBank : 82) / Drug target genes : 36 - Drug target pathways : 140

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02112838 (ClinicalTrials.gov)	October 2014	10/4/2014	Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy	A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study ...	IGA Nephropathy	Drug: Fostamatinib 150 mg;Drug: Fostamatinib 100 mg;Drug: Placebo	Rigel Pharmaceuticals	NULL	Completed	18 Years	70 Years	All	76	Phase 2	United States;Austria;Germany;Hong Kong;Taiwan;United Kingdom;Singapore;Switzerland
2	EUCTR2014-000331-16-AT (EUCTR)	25/08/2014	22/07/2014	N/A	A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study ...	IgA nephropathy (IgAN);Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]	Product Name: Fostamatinib 100 mg tablet Product Code: R935788 INN or Proposed INN: Fostamatinib Other ...	Rigel Pharmaceuticals Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	75	Phase 2	United States;Hong Kong;Taiwan;Singapore;Austria;United Kingdom;Switzerland
3	EUCTR2014-000331-16-GB (EUCTR)	28/07/2014	08/05/2014	N/A	A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study ...	IgA nephropathy (IgAN);Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]	Product Name: Fostamatinib 100 mg tablet Product Code: R935788 INN or Proposed INN: Fostamatinib Other ...	Rigel Pharmaceuticals Inc	NULL	Not Recruiting			Female: yes Male: yes	92	Phase 2	United States;Hong Kong;Taiwan;Singapore;Austria;Switzerland;United Kingdom

First Previous1Next Last